Global Burden and Temporal Trends of Testicular, Prostate, Kidney, and Bladder Cancers: An Analysis of the Global Burden of Disease Study 2023

Abstract Introduction: Urological cancers remain a substantial global health burden, with marked disparities across socioeconomic settings. This study assessed global trends and inequalities in bladder, kidney, prostate, and testicular cancers and projected mortality to 2040. Methods Data on mortality and disability-adjusted life years (DALYs) from 1990 to 2023 were obtained from the Global Burden of Disease Study 2023. Age-standardized mortality rates (ASMRs) and DALY rates (ASDRs) were analyzed by sex, region, and socio-demographic index (SDI). Temporal trends were assessed using estimated annual percentage change and Joinpoint regression. Bayesian age-period-cohort models projected mortality to 2040. Socioeconomic inequalities were evaluated using the slope index of inequality and concentration index. Results Globally, ASMRs and ASDRs for all four cancers declined from 1990 to 2023. However, substantial heterogeneity was observed across SDI strata, with increasing mortality for several cancers in low- and middle-SDI regions, particularly kidney and prostate cancers. Males consistently experienced higher mortality and DALY rates than females for bladder and kidney cancers. Absolute ASDR inequalities widened for bladder, kidney, and prostate cancers, whereas relative inequality decreased for kidney and prostate cancers, remained relatively stable for bladder cancer, and approached or crossed the null for testicular cancer. By 2040, mortality is projected to increase for testicular, prostate, and bladder cancers but decline for kidney cancer. Conclusions Global progress in urological cancer mortality has been uneven. These findings underscore the need to strengthen prevention, early detection, and access to cancer treatment in lower-SDI settings to address persistent health inequalities.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11495912/v1
Primary Topic
Global Cancer Incidence and Screening
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Global Burden and Temporal Trends of Testicular, Prostate, Kidney, and Bladder Cancers: An Analysis of the Global Burden of Disease Study 2023

Yang Liu, Jincong Li, Shudong Zhang
6 links
Research Square
Global Cancer Incidence and Screening
preprint

Global Burden and Temporal Trends of Testicular, Prostate, Kidney, and Bladder Cancers: An Analysis of the Global Burden of Disease Study 2023

Yang Liu, Jincong Li, Shudong Zhang
preprint en

Abstract

Abstract Introduction: Urological cancers remain a substantial global health burden, with marked disparities across socioeconomic settings. This study assessed global trends and inequalities in bladder, kidney, prostate, and testicular cancers and projected mortality to 2040. Methods Data on mortality and disability-adjusted life years (DALYs) from 1990 to 2023 were obtained from the Global Burden of Disease Study 2023. Age-standardized mortality rates (ASMRs) and DALY rates (ASDRs) were analyzed by sex, region, and socio-demographic index (SDI). Temporal trends were assessed using estimated annual percentage change and Joinpoint regression. Bayesian age-period-cohort models projected mortality to 2040. Socioeconomic inequalities were evaluated using the slope index of inequality and concentration index. Results Globally, ASMRs and ASDRs for all four cancers declined from 1990 to 2023. However, substantial heterogeneity was observed across SDI strata, with increasing mortality for several cancers in low- and middle-SDI regions, particularly kidney and prostate cancers. Males consistently experienced higher mortality and DALY rates than females for bladder and kidney cancers. Absolute ASDR inequalities widened for bladder, kidney, and prostate cancers, whereas relative inequality decreased for kidney and prostate cancers, remained relatively stable for bladder cancer, and approached or crossed the null for testicular cancer. By 2040, mortality is projected to increase for testicular, prostate, and bladder cancers but decline for kidney cancer. Conclusions Global progress in urological cancer mortality has been uneven. These findings underscore the need to strengthen prevention, early detection, and access to cancer treatment in lower-SDI settings to address persistent health inequalities.

Research Square
Peking University People's Hospital (CN), Peking University Third Hospital (CN)
Good health and well-being, Reduced inequalities
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon